Thank you for confirming your email address. You are now subscribed to the Businessweek Daily Newsletter.

©2013 Bloomberg LP. All rights reserved. Made in NYC. Privacy Policy
We are sorry, the article you requested is no longer available.

You are now being redirected to the home page for the latest articles.

The Long and the Short of It

A Notorious Short Seller Is Now Betting Long on Biotech's Future
A Notorious Short Seller Is Now Betting Long on Biotech's Future

Martin Shkreli made a name, and millions, short selling biotech startups. Now, as CEO of Retrophin, he's betting long.

Watch

Feed Headlines

Last Updated: 05:06 pm Market Summary

S&P500 1864.85 2.54
DJIA 16408.54 -16.31
NASDAQ 4095.516 9.291
Stoxx 50 3155.81 16.55
FTSE 100 6625.25 41.08
DAX 9409.71 91.89
Nikkei 14417.53 -.15
Topix 1166.59 .04
Hang Seng 22760.24 64.23

Sponsored Links

Buy a link now!

SPECIAL ADVERTISING